Research use only — not for human or veterinary use.
Retatrutide
Investigational triple receptor agonist acting at GIP, GLP-1 and glucagon receptors. Studied in metabolic research for energy balance, appetite signalling and body-composition endpoints.
- Vial
- 10 mg
- BAC water
- 2 ml
- Dose
- 0.5 mg
- Units (1 ml)
- 10
- Timing
- AM
- Frequency
- 3× per week
- Duration
- 8 weeks on, 8 weeks off (or until goal weight is reached)
Semaglutide
Long-acting GLP-1 receptor agonist. Widely used in metabolic research to examine insulin secretion, gastric emptying and satiety signalling.
- Vial
- 3 mg
- BAC water
- 2 ml
- Dose
- 250 mcg
- Units (1 ml)
- 17
- Timing
- AM
- Frequency
- Once per week
- Duration
- 8 weeks on, 8 weeks off
Tirzepatide
Dual GIP and GLP-1 receptor agonist. Studied for combined incretin signalling and its effect on glucose handling and appetite pathways.
- Vial
- 10 mg
- BAC water
- 2 ml
- Dose
- 0.5 mg
- Units (1 ml)
- 10
- Timing
- AM
- Frequency
- 3× per week
- Duration
- 8 weeks on, 8 weeks off (or until goal weight is reached)
AOD9604
Modified fragment (176–191) of human growth hormone. Investigated for lipolytic activity in adipose-tissue models without the broader growth-signalling profile of full-length hGH.
- Vial
- 5 mg
- BAC water
- 2 ml
- Dose
- 300 mcg
- Units (1 ml)
- 11
- Timing
- AM
- Frequency
- 5 days on, 2 days off
- Duration
- 8 weeks on, 8 weeks off
BPC 157
Synthetic pentadecapeptide derived from a gastric protective protein sequence. Studied extensively in tissue-repair models covering tendon, muscle, gut lining and new blood-vessel formation.
- Vial
- 10 mg
- BAC water
- 2 ml
- Dose
- 500 mcg
- Units (1 ml)
- 10
- Timing
- AM / PM
- Frequency
- Every day
- Duration
- 8 weeks on, 8 weeks off
BPC + TB Blend
Combination vial pairing BPC-157 with TB-500, a thymosin beta-4 fragment. Used where repair signalling and cell-migration pathways are examined together in the same model.
- Vial
- 5 mg / 5 mg
- BAC water
- 2 ml
- Dose
- 250 mcg / 250 mcg
- Units (1 ml)
- 10
- Timing
- AM / PM
- Frequency
- Every day
- Duration
- 8 weeks on, 8 weeks off
Figures are for the 5 mg / 5 mg vial.
Bacteriostatic Water
Sterile diluent containing 0.9% benzyl alcohol, used to reconstitute lyophilised research material. The preservative suppresses bacterial growth in multi-draw vials. Not a peptide.
B-12
Cobalamin solution. Included as a metabolic cofactor reference in research on methylation, energy pathways and as a carrier in blended lipotropic formulations.
Cagrilintide
Long-acting amylin analogue. Studied alongside incretin research for satiety signalling, gastric emptying and its additive effect when paired with GLP-1 agonists.
- Vial
- 5 mg
- BAC water
- 2 ml
- Dose
- 250 mcg
- Units (1 ml)
- 10
- Timing
- AM
- Frequency
- 3 days per week
- Duration
- 8 weeks on, 8 weeks off, or as needed for appetite suppression
CJC-1295 (no DAC)
Also known as Mod GRF (1-29): a growth-hormone-releasing hormone analogue without the drug-affinity complex, giving a short signalling window. Studied for pulsatile GH release.
- Vial
- 10 mg
- BAC water
- 3 ml
- Dose
- 200 mcg
- Units (1 ml)
- 6
- Timing
- PM
- Frequency
- 5 days on, 2 days off
- Duration
- 8 weeks on, 8 weeks off
CJC-1295 (no DAC) + IPA
Blend of Mod GRF (1-29) with ipamorelin, a ghrelin-receptor agonist. Used in research where the GHRH and GHRP pathways are stimulated in parallel.
- Vial
- 5 mg / 5 mg
- BAC water
- 2 ml
- Dose
- 250 mcg / 250 mcg
- Units (1 ml)
- 10
- Timing
- AM / PM
- Frequency
- 5 days on, 2 days off
- Duration
- 8 weeks on, 8 weeks off
Figures are for the 5 mg / 5 mg vial.
DSIP
Delta sleep-inducing peptide, a nonapeptide first isolated from rabbit cerebral venous blood. Investigated for slow-wave sleep architecture and stress-hormone modulation.
- Vial
- 5 mg
- BAC water
- 2 ml
- Dose
- 250 mcg
- Units (1 ml)
- 10
- Timing
- 1–3 hours before bed
- Frequency
- 5 days on, 2 days off
- Duration
- 8 weeks on, 8 weeks off
Epithalon
Synthetic tetrapeptide (Epitalon, AEDG) modelled on a pineal gland extract. Studied for telomerase activity, melatonin rhythm and circadian regulation in ageing research.
- Vial
- 20 mg
- BAC water
- 2 ml
- Dose
- 2 mg
- Units (1 ml)
- 20
- Timing
- PM
- Frequency
- Every day
- Duration
- 20 days in a row, 3× per year
FOXO4
FOXO4-DRI, a peptide designed to disrupt the FOXO4–p53 interaction. Used in senolytic research on the selective clearance of senescent cells.
- Vial
- 10 mg
- BAC water
- 2 ml
- Dose
- 1 mg
- Units (1 ml)
- 20
- Timing
- AM
- Frequency
- 5 days on, 2 days off
- Duration
- 2 weeks, repeat 2–3 times per year
Figures are for the 10 mg vial.
GHK-Cu
Copper tripeptide-1, a naturally occurring copper-binding peptide. Studied for collagen synthesis, wound remodelling and antioxidant signalling in skin and connective-tissue models.
- Vial
- 50 mg
- BAC water
- 3 ml
- Dose
- 1.7 mg
- Units (1 ml)
- 10
- Timing
- AM
- Frequency
- Every day
- Duration
- 8 weeks on, 8 weeks off
Ipamorelin
Selective ghrelin receptor (GHS-R) agonist and pentapeptide. Studied for growth-hormone release with minimal impact on cortisol or prolactin.
- Vial
- 10 mg
- BAC water
- 3 ml
- Dose
- 300 mcg
- Units (1 ml)
- 9
- Timing
- AM / PM
- Frequency
- 5 days on, 2 days off
- Duration
- 8 weeks on, 8 weeks off
Kisspeptin-10
Active fragment of the KISS1 gene product. Studied for its role upstream of GnRH in reproductive-axis signalling and hormone-release research.
- Vial
- 5 mg
- BAC water
- 2 ml
- Dose
- 125 mcg
- Units (1 ml)
- 5
- Timing
- 1 hour before bed
- Frequency
- Every day
- Duration
- 30 days on, 30 days off
Melanotan I
Afamelanotide, an α-MSH analogue selective for the MC1 receptor. Studied for melanogenesis and photoprotection endpoints.
- Vial
- 10 mg
- BAC water
- 2 ml
- Dose
- 250 mcg
- Units (1 ml)
- 5
- Timing
- AM
- Frequency
- 2 days per week
- Duration
- 8 weeks on, 8 weeks off
Melanotan II
Non-selective melanocortin agonist active across MC1R–MC5R. Studied for pigmentation, appetite and sexual-behaviour pathways in animal models.
MOTS-c (Human)
Mitochondrial-derived peptide encoded within mitochondrial DNA. Studied for AMPK activation, insulin sensitivity and exercise-related metabolic adaptation.
- Vial
- 10 mg
- BAC water
- 2 ml
- Dose
- 1 mg
- Units (1 ml)
- 20
- Timing
- AM
- Frequency
- 5 days on, 2 days off
- Duration
- 8 weeks on, 8 weeks off
NAD+
Nicotinamide adenine dinucleotide, a central redox cofactor. Studied in mitochondrial function, sirtuin activity and cellular-ageing research.
- Vial
- 500 mg
- BAC water
- 3 ml
- Dose
- 100 mg
- Units (1 ml)
- 100
- Timing
- AM
- Frequency
- 2–3 days per week
- Duration
- As needed
Figures are for the 500 mg vial.
PT-141
Bremelanotide, an MC3R/MC4R melanocortin agonist and metabolite of Melanotan II. Studied for central nervous system arousal pathways rather than vascular mechanisms.
- Vial
- 10 mg
- BAC water
- 2 ml
- Dose
- 500 mcg
- Units (1 ml)
- 10
- Timing
- 30 minutes before sexual activity
- Frequency
- As needed
- Duration
- As needed
Sermorelin Acetate
GHRH (1-29) analogue representing the shortest fully active fragment. Used as a physiological probe of pituitary growth-hormone reserve.
KPV
Lysine-proline-valine, the C-terminal tripeptide of α-MSH. Investigated for anti-inflammatory signalling, particularly in gut and skin models.
- Vial
- 10 mg
- BAC water
- 2 ml
- Dose
- 500 mcg
- Units (1 ml)
- 10
- Timing
- AM
- Frequency
- 5 days on, 2 days off
- Duration
- 8 weeks on, 8 weeks off
Selank
Heptapeptide analogue of the immunomodulatory peptide tuftsin. Studied for anxiolytic activity, GABAergic modulation and effects on BDNF expression.
- Vial
- 30 mg
- BAC water
- 3 ml
- Dose
- 1 mg
- Units (1 ml)
- 10
- Timing
- AM
- Frequency
- 2–3 days per week
- Duration
- 8 weeks on, 8 weeks off
Same figures apply to NA-Selank Amidate.
Semax
Analogue of the ACTH (4-10) fragment. Studied for neuroprotection, BDNF expression and attention or memory endpoints in rodent models.
- Vial
- 30 mg
- BAC water
- 3 ml
- Dose
- 1 mg
- Units (1 ml)
- 10
- Timing
- AM
- Frequency
- 2–3 days per week
- Duration
- 8 weeks on, 8 weeks off
Same figures apply to NA-Semax Amidate.
SS-31
Elamipretide, a mitochondria-targeted tetrapeptide with affinity for cardiolipin. Studied for inner-membrane integrity and oxidative-stress reduction.
- Vial
- 10 mg
- BAC water
- 2 ml
- Dose
- 500 mcg
- Units (1 ml)
- 10
- Timing
- AM
- Frequency
- 5 days on, 2 days off
- Duration
- 8 weeks on, 8 weeks off
TB-500
Synthetic fragment of thymosin beta-4. Studied for actin regulation, cell migration and new blood-vessel formation in tissue-repair models.
- Vial
- 10 mg
- BAC water
- 2 ml
- Dose
- 500 mcg
- Units (1 ml)
- 10
- Timing
- AM
- Frequency
- Every day
- Duration
- 8 weeks on, 8 weeks off
Tesamorelin
Stabilised GHRH analogue with an extended half-life. Studied for growth-hormone axis stimulation and visceral-adipose endpoints in metabolic research.
- Vial
- 10 mg
- BAC water
- 2 ml
- Dose
- 1 mg
- Units (1 ml)
- 20
- Timing
- AM / PM
- Frequency
- 5 days on, 2 days off
- Duration
- 8 weeks on, 8 weeks off
Thymalin / Thymulin
Thymic peptide preparations. Studied for T-cell maturation and immune regulation, most often in immunosenescence research.
- Vial
- 20 mg
- BAC water
- 2 ml
- Dose
- 2 mg
- Units (1 ml)
- 20
- Timing
- PM
- Frequency
- Every day
- Duration
- 20 days in a row, 3× per year
Thymosin Alpha-1
28-amino-acid thymic peptide. Studied for dendritic and T-cell activation through toll-like receptor signalling.
- Vial
- 10 mg
- BAC water
- 2 ml
- Dose
- 1.5 mg
- Units (1 ml)
- 30
- Timing
- AM
- Frequency
- 5 days on, 2 days off
- Duration
- 8 weeks on, 8 weeks off
IGF-1 LR3
Long R3 variant of insulin-like growth factor 1, engineered for an extended half-life and reduced binding-protein affinity. Studied for anabolic and cell-proliferation signalling.
- Vial
- 1 mg
- BAC water
- 1 ml
- Dose
- 50 mcg
- Units (1 ml)
- 5
- Timing
- AM
- Frequency
- 10 days in a row
- Duration
- 10 days on, 4 weeks off
Lipo-C
Lipotropic blend of methionine, inositol and choline. Used in metabolic research as a lipid-transport reference formulation. Not a peptide.
MIC (Lipo-C + B-12)
Methionine, inositol and choline combined with B-12. A blended lipotropic reference formulation used in metabolic research.
Lemon Bottle
Proprietary lipolytic solution combining riboflavin, bromelain and lecithin. Studied in adipose-tissue models for localised fat-cell breakdown.
VIP
Vasoactive intestinal peptide, a 28-amino-acid neuropeptide. Studied for immune modulation, circadian signalling and mucosal or vascular research.
- Vial
- 5 mg
- BAC water
- 5 ml
- Dose
- 50 mcg
- Units (1 ml)
- 5
- Timing
- AM / PM
- Frequency
- Every day
- Duration
- 8 weeks on, 8 weeks off
GLOW
Blend of BPC-157, GHK-Cu and TB-500 in a single vial. Brings repair signalling, collagen synthesis and cell migration into one research preparation.
- Vial
- 10 mg / 10 mg / 50 mg
- BAC water
- 2 ml
- Dose
- 2.5 mg / 500 mcg / 500 mcg
- Units (1 ml)
- 10
- Timing
- AM or PM
- Frequency
- 5 days on, 2 days off
- Duration
- 8 weeks on, 8 weeks off
Order is BPC-157 / TB-500 / GHK-Cu.
P21 (P021)
Peptidomimetic derived from a CNTF neurotrophic fragment. Studied for neurogenesis, BDNF signalling and tau-related endpoints in neurodegeneration models.
5-AMINO-1MQ
Small-molecule NNMT inhibitor. Studied for nicotinamide salvage, intracellular NAD+ levels and adipocyte metabolism. Not a peptide.
KLOW
Blend of BPC-157, GHK-Cu, TB-500 and KPV. Combines repair, collagen, cell-migration and anti-inflammatory pathways in one research preparation.
- Vial
- 10 mg / 10 mg / 10 mg / 50 mg
- BAC water
- 2 ml
- Dose
- 500 mcg
- Units (1 ml)
- 10
- Timing
- AM or PM
- Frequency
- 5 days on, 2 days off
- Duration
- 8 weeks on, 8 weeks off
Order is BPC-157 / TB-500 / KPV / GHK-Cu.